Industry sponsored studies twice as likely to have positive conclusions about costs

Researchers have warned of the risk of sponsorship bias in health economic studies in the field of cancer.

Industry sponsored studies were twice as likely to be cost minimisation analyses, which compare equally effective treatments on the basis of costs. The industry studies were 2.5 times …